• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病和非糖尿病腹膜透析患者的容量控制

Volume control in diabetic and nondiabetic peritoneal dialysis patients.

作者信息

Gan Hong-bing, Chen Meng-hua, Lindholm Bengt, Wang Tao

机构信息

Institute of Nephrology, First Hospital, Peking University, 8 Xishiku Street, Beijing, 100034, P.R.China.

出版信息

Int Urol Nephrol. 2005;37(3):575-9. doi: 10.1007/s11255-005-1202-4.

DOI:10.1007/s11255-005-1202-4
PMID:16307345
Abstract

UNLABELLED

Diabetic patients especially the elderly have higher mortality on peritoneal dialysis treatment as compared to nondiabetic patients. As fluid overload is an important contributor for the high dropout rate in peritoneal dialysis therapy, the present study tried to compare the fluid status in diabetic and non-diabetic peritoneal dialysis patients and to investigate the effect of salt and water restriction on fluid status in diabetic peritoneal dialysis patients.

METHODS

A cross sectional study was performed in 58 peritoneal dialysis patients who had been treated for at least 3 months. Among them, 20 patients were diabetics and the others were nondiabetics. We reviewed their dialysis prescription, peritoneal ultrafiltration, urine volume and fluid status. Then the 20 diabetic patients were advised to restrict their salt and water intake and were followed for 3 months.

RESULTS

During the cross sectional study there were no significant differences in age, gender, height and urine volume between the diabetic and nondiabetic patients. However, body weight, normalized extracellular water (nECW), dialysis dose, dialysate glucose load, peritoneal ultrafiltration, total fluid removal and the prevalence and extent of edema were all significantly higher in diabetics as compared to nondiabetics. After restricting salt and water intake, body weight, nECW, edema, fasting blood glucose, dialysate dose, dialysate glucose load, peritoneal ultrafiltration and total fluid removal were all significantly decreased, whereas the urine volume did not change significantly.

CONCLUSIONS

The present study suggests that diabetic patients were more fluid overloaded as compared to nondiabetics despite use of more hypertonic glucose solutions and, as a consequence, higher peritoneal ultrafiltration and higher total fluid removal; this indicates that our diabetic patients must have had significantly higher salt and fluid intakes. It also suggests that restricting salt and water intake can effectively treat fluid overload in diabetic peritoneal dialysis patients. Dietary salt and fluid restriction may help reduce the use of hypertonic glucose solution and thus facilitate the blood glucose control in diabetic patients undergoing peritoneal dialysis.

摘要

未标注

与非糖尿病患者相比,糖尿病患者尤其是老年患者在腹膜透析治疗中的死亡率更高。由于液体超负荷是腹膜透析治疗中高退出率的一个重要因素,本研究试图比较糖尿病和非糖尿病腹膜透析患者的液体状态,并研究限盐和限水对糖尿病腹膜透析患者液体状态的影响。

方法

对58例接受腹膜透析治疗至少3个月的患者进行了横断面研究。其中,20例为糖尿病患者,其余为非糖尿病患者。我们回顾了他们的透析处方、腹膜超滤、尿量和液体状态。然后建议20例糖尿病患者限制盐和水的摄入量,并随访3个月。

结果

在横断面研究中,糖尿病患者和非糖尿病患者在年龄、性别、身高和尿量方面无显著差异。然而,与非糖尿病患者相比,糖尿病患者的体重、标准化细胞外液(nECW)、透析剂量、透析液葡萄糖负荷、腹膜超滤、总液体清除量以及水肿的发生率和程度均显著更高。限制盐和水的摄入量后,体重、nECW、水肿、空腹血糖、透析液剂量、透析液葡萄糖负荷、腹膜超滤和总液体清除量均显著降低,而尿量无显著变化。

结论

本研究表明,尽管使用了更多高渗葡萄糖溶液,因此腹膜超滤和总液体清除量更高,但糖尿病患者比非糖尿病患者更容易出现液体超负荷;这表明我们的糖尿病患者盐和液体摄入量一定显著更高。研究还表明,限制盐和水的摄入量可以有效治疗糖尿病腹膜透析患者的液体超负荷。饮食限盐和限水可能有助于减少高渗葡萄糖溶液的使用,从而有助于接受腹膜透析的糖尿病患者控制血糖。

相似文献

1
Volume control in diabetic and nondiabetic peritoneal dialysis patients.糖尿病和非糖尿病腹膜透析患者的容量控制
Int Urol Nephrol. 2005;37(3):575-9. doi: 10.1007/s11255-005-1202-4.
2
Peritoneal Water Transport Characteristics of Diabetic Patients Undergoing Peritoneal Dialysis: A Longitudinal Study.接受腹膜透析的糖尿病患者的腹膜水转运特征:一项纵向研究。
Am J Nephrol. 2017;46(1):47-54. doi: 10.1159/000477829. Epub 2017 Jun 21.
3
Does diabetes mellitus predispose to increased fluid overload in peritoneal dialysis patients?糖尿病是否使腹膜透析患者易发生液体超负荷?
Nephron Clin Pract. 2010;114(1):c60-6. doi: 10.1159/000245070. Epub 2009 Oct 9.
4
Residual renal function and volume control in peritoneal dialysis patients.腹膜透析患者的残余肾功能与容量控制
Nephron Clin Pract. 2006;104(1):c47-54. doi: 10.1159/000093670. Epub 2006 May 1.
5
Comparisons of peritoneal function between diabetic and nondiabetic patients with end stage renal disease.糖尿病和非糖尿病终末期肾病患者腹膜功能的比较。
Gaoxiong Yi Xue Ke Xue Za Zhi. 1990 Nov;6(11):621-7.
6
Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.持续性非卧床腹膜透析(CAPD)开始时糖尿病患者与非糖尿病患者之间液体和溶质转运的差异。
Adv Perit Dial. 1997;13:29-32.
7
Salt and fluid intake in the development of hypertension in peritoneal dialysis patients.腹膜透析患者高血压发生过程中的盐和液体摄入
Ren Fail. 2007;29(4):427-32. doi: 10.1080/08860220701260461.
8
Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.腹膜透析超滤失败患者对艾考糊精良好反应的预测因素。
Nephrology (Carlton). 2005 Feb;10(1):33-6. doi: 10.1111/j.1440-1797.2005.00361.x.
9
A Patient on Peritoneal Dialysis with Refractory Volume Overload.一名腹膜透析患者伴有难治性容量超负荷。
Clin J Am Soc Nephrol. 2016 Jan 7;11(1):155-60. doi: 10.2215/CJN.02920315. Epub 2015 Jul 16.
10
Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.透明质酸可防止因腹膜透析液填充量增加而导致的净超滤减少。
Kidney Int. 1998 Feb;53(2):496-502. doi: 10.1046/j.1523-1755.1998.00773.x.

引用本文的文献

1
Effect of the Chronic Kidney Disease-Peritoneal Dialysis (CKD-PD) App on Improvement of Overhydration Treatment in Patients on Peritoneal Dialysis: Randomized Controlled Trial.慢性肾脏病-腹膜透析(CKD-PD)应用程序对腹膜透析患者水钠潴留治疗改善效果的随机对照试验
J Med Internet Res. 2025 May 21;27:e70641. doi: 10.2196/70641.
2
Perspective: Multiomics and Artificial Intelligence for Personalized Nutritional Management of Diabetes in Patients Undergoing Peritoneal Dialysis.视角:多组学与人工智能在腹膜透析患者糖尿病个性化营养管理中的应用
Adv Nutr. 2025 Mar;16(3):100378. doi: 10.1016/j.advnut.2025.100378. Epub 2025 Jan 20.
3

本文引用的文献

1
Beyond CANUSA, DOQI, ADEMEX: what's next? Adequacy of Peritoneal Dialysis in Mexico. Canada-USA. Dialysis Outcomes Quality Initiative.超越加拿大-美国合作研究、美国肾脏病预后质量倡议、墨西哥腹膜透析充分性研究:接下来是什么?墨西哥腹膜透析的充分性。加拿大-美国。透析预后质量倡议。
Perit Dial Int. 2002 Sep-Oct;22(5):555-62.
2
Hemodialysis (HD) versus peritoneal dialysis (PD): latent overhydration in PD patients?血液透析(HD)与腹膜透析(PD):腹膜透析患者存在潜在水过多吗?
Int J Artif Organs. 2002 Sep;25(9):838-43. doi: 10.1177/039139880202500905.
3
Dietary salt restriction and drug-free treatment of hypertension in ESRD patients: a largely abandoned therapy.
Predictors and prognostic significance of the volume load trajectory: a longitudinal study in patients on peritoneal dialysis.
容量负荷轨迹的预测因素和预后意义:腹膜透析患者的纵向研究。
Ren Fail. 2024 Dec;46(2):2405561. doi: 10.1080/0886022X.2024.2405561. Epub 2024 Sep 20.
4
Effect of Time Interval and Frequency of Hospitalization Because of Fluid Overload on Survival in Peritoneal Dialysis: Thailand Experience.因液体过载导致的住院时间间隔和频率对腹膜透析患者生存的影响:泰国经验
Kidney360. 2024 Nov 1;5(11):1675-1682. doi: 10.34067/KID.0000000576. Epub 2024 Sep 11.
5
DETERMINATION OF VOLUME OVERLOAD BY BIOELECTRICAL IMPEDANCE ANALYSIS AND NT-PROBNP IN DIABETIC PRE-DIALYSIS PATIENTS.通过生物电阻抗分析和NT-脑钠肽前体测定糖尿病透析前患者的容量超负荷情况
Acta Endocrinol (Buchar). 2016 Jan-Mar;12(1):19-25. doi: 10.4183/aeb.2016.19.
6
Influence of peritoneal transport characteristics on nutritional status and clinical outcome in Chinese diabetic nephropathy patients on peritoneal dialysis.腹膜转运特性对中国糖尿病肾病腹膜透析患者营养状况及临床结局的影响
Chin Med J (Engl). 2015 Apr 5;128(7):859-64. doi: 10.4103/0366-6999.154275.
7
Is fluid overload more important than diabetes in renal progression in late chronic kidney disease?在晚期慢性肾脏病的肾脏进展中,液体超负荷是否比糖尿病更重要?
PLoS One. 2013 Dec 9;8(12):e82566. doi: 10.1371/journal.pone.0082566. eCollection 2013.
8
High glucose concentrations in peritoneal dialysate are associated with all-cause and cardiovascular disease mortality in continuous ambulatory peritoneal dialysis patients.腹膜透析液中的高葡萄糖浓度与持续性非卧床腹膜透析患者的全因死亡率和心血管疾病死亡率相关。
Perit Dial Int. 2015 Jan-Feb;35(1):70-7. doi: 10.3747/pdi.2013.00083. Epub 2013 Dec 1.
终末期肾病(ESRD)患者的饮食限盐与高血压的非药物治疗:一种基本被摒弃的疗法。
Nephrol Dial Transplant. 2002 Jul;17(7):1163-5. doi: 10.1093/ndt/17.7.1163.
4
A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance.一种通过全身生物阻抗测定血液透析患者干体重的新技术。
Kidney Int. 2002 Jun;61(6):2250-8. doi: 10.1046/j.1523-1755.2002.00377.x.
5
Peritoneal and hemodialysis: II. Mortality risk associated with initial patient characteristics.腹膜透析和血液透析:II. 与患者初始特征相关的死亡风险。
Kidney Int. 2002 Feb;61(2):741-6. doi: 10.1046/j.1523-1755.2002.00176.x.
6
Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods.通过生物物理和生化方法评估慢性血液透析和腹膜透析患者的体液分布比较。
Nephrol Dial Transplant. 2001 Dec;16(12):2378-85. doi: 10.1093/ndt/16.12.2378.
7
Long-term survival with peritoneal dialysis in ESRD due to diabetes.糖尿病所致终末期肾病患者接受腹膜透析的长期生存情况。
Clin Nephrol. 2001 Oct;56(4):257-70.
8
Effect of fluid and sodium removal on mortality in peritoneal dialysis patients.液体和钠清除对腹膜透析患者死亡率的影响。
Kidney Int. 2001 Aug;60(2):767-76. doi: 10.1046/j.1523-1755.2001.060002767.x.
9
Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients.长期接受持续性非卧床腹膜透析的患者血容量增加,且与血液透析患者相比,表现出更严重的左心室肥厚。
Nephrol Dial Transplant. 2001 Jul;16(7):1459-64. doi: 10.1093/ndt/16.7.1459.
10
Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis.腹膜透析时腹膜葡萄糖暴露及膜溶质转运随时间的变化
J Am Soc Nephrol. 2001 May;12(5):1046-1051. doi: 10.1681/ASN.V1251046.